At the 2021 Virtual Conference on Retroviruses and Opportunistic Infections (CROI), UW researchers shared groundbreaking research aimed at preventing and treating HIV and other sexually transmitted infections (STIs).
The Conference on Retroviruses and Opportunistic Infections (CROI) took place in Seattle in mid-February, a forum for researchers and advocates to discuss the basic science and clinical discoveries of human retroviruses and associated diseases.
Sharon Greene, MPH student in Epidemiology at the UW School of Public Health, presented findings during CROI on a 3-year study comparing the effectiveness of cryotherapy and loop electrosurgical excision procedure (LEEP) to eliminate risk of cervical pre-cancer for women living with HIV.
By Lisa Rossi
Two large clinical trials have found that a microbicide prevention method can safely help reduce new HIV infections in women.
Results of the ASPIRE trial, which enrolled more than 2,600 women in Africa, were announced today at the Conference on Retroviruses and Opportunistic Infections in Boston. The results also will be published online in the New England Journal of Medicine.